As shown in Figures 4E-G, ALT, AST, and BUN levels were within the normal range in all the treatment groups, indicating that ST08 can be used with cisplatin for combination therapy resulting in tumor reduction, minimal side effects, and least toxicity. The gene discussed is GPT; the disease is neoplasm.